Gene Regulation: Mechanisms, Technologies, Disease, Therapy

Hana Kobayashi^*
*Correspondence: Hana Kobayashi, Department of Clinical Genetics, Kyoto Advanced Biomedical Research Center, Kyoto, Japan, Email:

Introduction

Single-cell multi-omics technologies are truly revolutionizing our understanding of gene regulation and cell states. These methods integrate genomic, epigenomic, transcriptomic, and proteomic data from individual cells, revealing complex regulatory networks and cell-specific characteristics. This offers vital insights into developmental processes, disease mechanisms, and potential therapeutic avenues [1].

Let's explore the basics of epigenetic gene regulation, which includes DNA methylation, histone modifications, and non-coding RNAs. These mechanisms profoundly impact gene expression, and their dysregulation contributes significantly to diseases, particularly cancer. The discussion often extends to emerging therapeutic strategies that specifically target these epigenetic pathways to control gene expression for treatment [2].

Here's the thing about long non-coding RNAs (lncRNAs): they're crucial players in gene expression. These articles detail their various mechanisms, ranging from chromatin remodeling to post-transcriptional control. They underscore their significant involvement in core cellular processes and their roles in numerous diseases, especially cancer, pointing to their potential as diagnostic markers and treatment targets [3].

This review explores the power of CRISPR-based tools for precise gene expression control, moving beyond just genome editing. It covers systems like CRISPRa and CRISPRi, along with base and prime editors. These tools allow researchers to fine-tune gene transcription, correct genetic errors, and meticulously study gene function. What this really means is it opens doors for advanced gene therapies and functional genomics [4].

Understanding the complex gene expression patterns in neurodevelopmental disorders is key, and this article tackles just that. It discusses how disruptions in regulatory mechanisms contribute to these conditions, covering both genetic and epigenetic influences on neuronal development. Advanced transcriptomic approaches are highlighted for identifying disease genes and pathways, which ultimately improves diagnosis and treatment strategies [5].

Spatial transcriptomics is a powerful tool, as this review explains, for mapping gene expression while keeping tissue structure intact. It shows how these methods move beyond traditional sequencing limits by pinpointing transcript locations within tissue. This offers crucial insights into cell-cell interactions, tissue variations, and disease progression in a spatially resolved way [6].

Circular RNAs (circRNAs) are proving to be key players in gene expression regulation. This article explores their growing roles as miRNA sponges, protein scaffolds, and even translation templates. It details their biogenesis, diverse cellular functions, and their increasing relevance in various diseases, like cancer and neurodegeneration, marking circRNAs as promising biomarkers and therapeutic targets [7].

The connection between cellular metabolism and gene expression is a fascinating one. This review highlights how metabolic intermediates and pathways directly influence everything from chromatin structure to mRNA stability. It explains how metabolic signals can reprogram gene expression, allowing cells to adapt to different environments, with major implications for metabolic diseases, cancer, and the aging process [8].

This article outlines the advancements in RNA sequencing (RNA-seq) technologies, including single-cell, spatial, and long-read RNA-seq, and their impact on gene expression profiling. These methods offer a way to move past bulk measurements, capturing transcriptional diversity, isoform complexity, and the spatial arrangement of RNA. What this really means is an unprecedented level of detail in understanding gene regulation in both health and disease [9].

Let's break down post-transcriptional gene regulation: RNA-binding proteins (RBPs) are central to it. This review highlights their critical roles in everything from mRNA splicing to translation. It shows how RBP dysfunction or altered expression can contribute to various human diseases, including neurological disorders and cancer, making RBPs exciting targets for both diagnostics and therapeutics [10].

Description

Understanding gene expression regulation is foundational to grasping cellular functions and disease progression. Epigenetic mechanisms, including DNA methylation, histone modifications, and the involvement of non-coding RNAs, profoundly influence gene expression. Dysregulation of these processes is a known contributor to various diseases, especially cancer, highlighting their importance in therapeutic strategies [2]. Beyond epigenetics, long non-coding RNAs (lncRNAs) are pivotal players, acting through mechanisms from chromatin remodeling to post-transcriptional control. They are significantly involved in core cellular processes and contribute to numerous diseases, including cancer, making them potential diagnostic markers and treatment targets [3]. Similarly, circular RNAs (circRNAs) have emerged as key regulators, functioning as miRNA sponges, protein scaffolds, and even translation templates. Their diverse cellular roles and relevance in diseases like cancer and neurodegeneration mark them as promising biomarkers and therapeutic targets [7]. Post-transcriptional gene regulation, largely orchestrated by RNA-binding proteins (RBPs), involves critical processes from mRNA splicing to translation. Dysfunction or altered expression of RBPs is implicated in various human diseases, such as neurological disorders and cancer, positioning RBPs as exciting targets for diagnostics and therapeutics [10].

The landscape of gene expression profiling has been dramatically reshaped by advanced technologies. Single-cell multi-omics technologies are at the forefront, integrating genomic, epigenomic, transcriptomic, and proteomic data from individual cells. This revolutionary approach reveals complex regulatory networks and cell-specific characteristics, offering vital insights into developmental processes, disease mechanisms, and potential therapeutic avenues [1]. Complementing this, spatial transcriptomics provides a powerful means to map gene expression while preserving tissue structure. This method moves beyond traditional sequencing limits by precisely pinpointing transcript locations within tissues, offering crucial insights into cell-cell interactions, tissue variations, and disease progression in a spatially resolved manner [6]. Broader advancements in RNA sequencing (RNA-seq) technologies, encompassing single-cell, spatial, and long-read RNA-seq, have transformed comprehensive gene expression profiling. These methods allow researchers to move past bulk measurements, capturing transcriptional diversity, isoform complexity, and the spatial arrangement of RNA, leading to an unprecedented level of detail in understanding gene regulation in both health and disease [9].

Precision control over gene expression has also seen significant strides with CRISPR-based tools. These technologies extend beyond basic genome editing to offer programmable gene expression control. Systems like CRISPRa and CRISPRi, alongside base and prime editors, enable researchers to fine-tune gene transcription, correct genetic errors, and meticulously study gene function. This suite of tools opens new doors for advanced gene therapies and functional genomics, providing unprecedented specificity in manipulating cellular processes [4].

The implications of altered gene expression are profound across a spectrum of human health conditions. For instance, understanding the complex gene expression patterns in neurodevelopmental disorders is critical. Disruptions in regulatory mechanisms, including genetic and epigenetic influences on neuronal development, contribute to these conditions. Advanced transcriptomic approaches are vital for identifying specific disease genes and pathways, which, in turn, improves diagnosis and treatment strategies for these challenging disorders [5].

Furthermore, the interplay between cellular metabolism and gene expression presents a fascinating area of study. Metabolic intermediates and pathways directly influence various aspects of gene regulation, from chromatin structure to mRNA stability. Metabolic signals can reprogram gene expression, enabling cells to adapt effectively to different environmental cues. This connection holds major implications for the understanding and treatment of metabolic diseases, cancer development, and the intricate processes of aging [8].

Conclusion

Understanding gene regulation is paramount for comprehending cell states, development, and disease. This collection highlights diverse facets of gene expression control, from epigenetic mechanisms involving DNA methylation, histone modifications, and non-coding RNAs to the specific roles of long non-coding RNAs and circular RNAs in various cellular processes and diseases. Advanced technologies like single-cell multi-omics and spatial transcriptomics are revolutionizing our ability to profile gene expression with unprecedented detail, moving beyond bulk measurements to capture cell-specific characteristics, transcriptional diversity, and spatial arrangement within tissues. CRISPR-based tools offer precise control over gene expression, enabling researchers to fine-tune transcription and correct genetic errors, paving the way for advanced gene therapies. The intricate connection between cellular metabolism and gene expression reveals how metabolic signals can reprogram cellular functions, impacting diseases and aging. Furthermore, the role of RNA-binding proteins in post-transcriptional regulation is critical, with their dysfunction linked to various human ailments. By exploring these mechanisms and leveraging sophisticated sequencing technologies, we gain crucial insights into neurodevelopmental disorders and other complex diseases, ultimately improving diagnostic and therapeutic strategies.

Acknowledgement

None

Conflict of Interest

None

References

Jianan Z, Fan-Yi S, Zi-Jun Y. "Single-cell multi-omics for understanding gene regulation and cell states".Nat Methods 20 (2023):1445-1456.

Indexed at, Google Scholar, Crossref

Tingting Z, Ling L, Xin L. "Epigenetic regulation of gene expression: from basic mechanisms to therapeutic implications".Cell Mol Life Sci 79 (2022):564.

Indexed at, Google Scholar, Crossref

Jia L, Yu-Jing Y, Hai-Ying S. "The role of long non-coding RNAs in regulating gene expression and disease".J Exp Clin Cancer Res 40 (2021):366.

Indexed at, Google Scholar, Crossref

Kaiyue M, Chunyu J, Xiaojie Z. "CRISPR-based technologies for programmable gene expression and genome engineering".Mol Ther Nucleic Acids 32 (2023):574-585.

Indexed at, Google Scholar, Crossref

Sara LC, Catherine ED, John MO. "Decoding the complexity of gene expression in neurodevelopmental disorders".Neurogenetics 21 (2020):119-129.

Indexed at, Google Scholar, Crossref

Xiao-Jie Z, Zi-Fan L, Bo-Qian L. "Spatial transcriptomics: unraveling gene expression in tissue context".Mol Cell Biol 42 (2022):e0030022.

Indexed at, Google Scholar, Crossref

Yu-Ting L, Jian-Peng L, Min-Min L. "Circular RNAs: A new frontier in gene expression regulation and disease".Cell Death Dis 12 (2021):22.

Indexed at, Google Scholar, Crossref

Ji-Yeong K, Hyun-Ju K, Seung-Hyun L. "Metabolic regulation of gene expression and cellular function".Exp Mol Med 52 (2020):1-13.

Indexed at, Google Scholar, Crossref

Ya-Li W, Min L, Jian-Ming L. "Advanced RNA sequencing technologies for comprehensive gene expression profiling".Front Cell Dev Biol 11 (2023):1118671.

Indexed at, Google Scholar, Crossref

Wei Z, Hui L, Yuan L. "Post-transcriptional regulation of gene expression by RNA-binding proteins in disease".Cell Rep 39 (2022):110626.

Indexed at, Google Scholar, Crossref